After government approval of Sputnik V, Russia’s first COVID-19 vaccine, on August 11, 2020, health authorities have, on October 14, 2020, approved its second vaccine, EpiVacCorona, developed by Novosibirsk’s Vektor [State Virology and Biotechnology Center], as it starts large-scale trials. According to President Putin, his deputy prime minister and the …
Read More »
Medicosnext